CATH2 derivatives

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10829524
APP PUB NO 20170145065A1
SERIAL NO

15310034

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides new derivatives of CATH2 or CMAP27, one of the cathelicidins. These derivatives comprise N-terminally truncated peptides, cyclic peptides, D-amino acid variants of CATH2 and its truncated derivatives, inverso and retroinverso CATH2 derivatives. These derivatives are useful as anti-infectives, in vaccines, and especially for in ovo applications. Further, for the above derivatives and also for the already known C-terminally truncated derivatives new immunoactivating functions have been described that are particularly advantageous for prophylactic treatments.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNIVERSITEIT UTRECHT HOLDING B VYALELAAN 40 UTRECHT 3584 CM

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Haagsman, Hendrik Peter Utrecht, NL 7 4
van, Dijk Albert Utrecht, NL 9 2
Veldhuizen, Edwin Johannes Adrianus Utrecht, NL 8 2

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 May 10, 2028
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 10, 2032
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00